MedWatch
HomeShortagesCategoriesAbout
Home/Boehringer Ingelheim

Boehringer Ingelheim

12 PBS-listed medicines1 current shortage

AnticoagulantsSGLT2 InhibitorsCOPDBronchodilatorsParkinson's DiseaseUrologyNSAIDsAntispasmodicsChronic Kidney DiseaseARBsDPP-4 Inhibitors
dabigatran etexilate

Pradaxa · 150 mg · Anticoagulants

$31.60
general
empagliflozin

Jardiance · 10 mg · SGLT2 Inhibitors

Anticipated shortage

$31.60
general
tiotropium bromide

Spiriva Handihaler · 18 mcg · COPD

In shortage

$31.60
general
ipratropium bromide

Atrovent · 20 mcg/dose · Bronchodilators

$24.80
general
pramipexole dihydrochloride

Sifrol · 0.125 mg · Parkinson's Disease

$31.60
general
tamsulosin hydrochloride

Flomax · 400 mcg · Urology

$28.40
general
meloxicam

Mobic · 15 mg · NSAIDs

$18.40
general
meloxicam

Mobic · 7.5 mg · NSAIDs

$16.40
general
hyoscine butylbromide

Buscopan · 10 mg · Antispasmodics

$10.40
general
empagliflozin

Jardiance · 25 mg · Chronic Kidney Disease

Anticipated shortage

$31.60
general
telmisartan

Micardis · 80 mg · ARBs

$28.40
general
linagliptin

Trajenta · 5 mg · DPP-4 Inhibitors

$31.60
general

MedWatch is for informational purposes only and does not constitute medical advice. Never stop or change your medicines without consulting your doctor or pharmacist. In an emergency, call 000. Medication queries: National Medicines Line 1300 633 424.

Part of the OTG Civic Tech Suite:Off The Ground Agency·SpendWatch·MedWatch·RentSmart·AviCheck·recallau

MedWatch

Australian medicine shortage and price tracking.

Data sourced from PBS (Australian Government) and TGA Medicine Shortages

Built by Off The Ground Agency

MedWatch is for informational purposes only. Always consult your pharmacist or prescriber before making changes to your medication. Data is updated regularly but may not reflect real-time availability.

HomeShortagesBrowseAbout